Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,776 | -51,263 | -26,070 | -93,317 | -70,547 |
| Depreciation Amortization | 8,039 | 4,102 | 2,058 | 8,300 | 6,366 |
| Accounts receivable | -108 | -851 | -737 | -247 | -779 |
| Accounts payable and accrued liabilities | -3,311 | -1,459 | -1,111 | -2,794 | -4,062 |
| Other Working Capital | 2,718 | 364 | 1,095 | -8,536 | -11,084 |
| Other Operating Activity | 8,483 | 4,784 | 3,065 | 7,578 | 8,341 |
| Operating Cash Flow | $-62,955 | $-44,323 | $-21,700 | $-89,016 | $-71,765 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,652 | 32,600 | 2,575 | 12,139 | 10,927 |
| PPE Investments | -834 | -533 | -476 | -262 | -193 |
| Net Acquisitions | -5,561 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -59,955 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 60,550 |
| Investing Cash Flow | $31,257 | $32,067 | $2,099 | $11,877 | $11,329 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,377 | 11,377 | 750 | 38,592 | 38,592 |
| Debt Repayment | -49,587 | -33,319 | -2,916 | -2,120 | -1,470 |
| Common Stock Issued | 181,491 | 181,491 | 181,488 | 55,436 | 265 |
| Common Stock Repurchased | -149 | -149 | -149 | -88 | -88 |
| Financing Cash Flow | $143,132 | $159,400 | $179,173 | $91,820 | $37,299 |
| Beginning Cash Position | 100,554 | 100,554 | 100,554 | 85,873 | 85,873 |
| End Cash Position | 211,988 | 247,698 | 260,126 | 100,554 | 62,736 |
| Net Cash Flow | $111,434 | $147,144 | $159,572 | $14,681 | $-23,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,955 | -44,323 | -21,700 | -89,016 | -71,765 |
| Capital Expenditure | -878 | -562 | -485 | -369 | -303 |
| Free Cash Flow | -63,833 | -44,885 | -22,185 | -89,385 | -72,068 |